Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)

NCT03242928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Cocaine-related Disorder

Interventions

DRUG: AFQ056
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals